Injective and Solana have achieved cross-chain name service, as announced by Injective. This advancement facilitates interoperability with the release of the first-ever omnichain domain for both platforms. Users can now interact with other ecosystems without changing domains, offering a seamless experience. Essentially, users only need to use a single domain name to transact across Solana and Injective.

To illustrate, users can utilize INJ to obtain the .sol domain. This development also sets the stage for integrating Phantom, bringing Solana and Injective closer and enhancing connectivity with Solana. Users can initiate their omnichain domain experience by connecting their wallet to Injective, followed by searching for the desired domain and registering it, with payments processed in INJ tokens.

The omnichain domain release marks a significant technical breakthrough, improving user experience and strengthening the relationship between Solana and Injective. Despite the promising announcement, native tokens have yet to show bullish signals, with INJ and SOL experiencing slight declines in the past 24 hours.

This development represents an unprecedented innovation in blockchain technology, following a year-long planning process and stress testing on the testnet. Moving forward, Solana and Injective aim to enhance the developer experience by unifying their ecosystems further, with the launch of inSVM expected to mark the first Solana-focused rollup.

Users interested in creating a .inj name service can visit Injective's official website, navigate to Connect, select a preferred wallet, search for the domain name, and follow the instructions to proceed.